The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Prevenar 13



Pfizer Europe MA EEIGEU/1/09/590/1-6

Main Information

Trade NamePrevenar 13
Active SubstancesPolysaccharide serotype 14
Polysaccharide serotype 23f
Polysaccharide serotype 19f
Polysaccharide serotype 9v
Polysaccharide serotype 3
Polysaccharide serotype 1
Polysaccharide serotype 6a
Polysaccharide serotype 7f
Polysaccharide serotype 4
Polysaccharide serotype 6b
Oligosaccharide serotype 18c
Polysaccharide serotype 5
Polysaccharide serotype 19a
Dosage FormSuspension for injection
Licence HolderPfizer Europe MA EEIG
Licence NumberEU/1/09/590/1-6

Group Information

ATC CodeJ07AL Pneumococcal vaccines
J07AL02 pneumococcus, purified polysaccharides antigen conjugated

Status

License statusAuthorised
Licence Issued09/12/2009
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back